New gene therapy for the treatment of children with ultra-rare immune disorder recommended for approval

View source ↗

Summary

The EMA recommends approval of a new gene therapy for treating children with an ultra-rare immune disorder, signaling a potential market authorization subject t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency May Be Implied But Not Specified in Title
• Ultra-rare Immune Disorder